CBD & Jaw Pain: A Randomized Trial
Published: Medical Cannabis and Cannabinoids, January 2026
Researchers: Reeve, Kutler, Abel et al. — Weill Cornell Medicine, New York — prospective, double-blind, randomized, placebo-controlled trial
1. What Was Studied?
Myofascial pain disorder of the temporomandibular region — more commonly known as jaw pain or TMJ disorder — involves chronic pain in the jaw muscles that affects eating, speaking, and sleep. It's one of the most common orofacial pain conditions globally and is often difficult to treat effectively with standard approaches.
This was the first prospective, double-blind, randomized, placebo-controlled trial of oral CBD specifically for this condition. Participants with clinically diagnosed jaw pain (scoring at least 30 out of 100 on a pain scale) were randomly assigned to receive either CBD or hemp seed oil placebo for three months. Pain and jaw function were measured at one, two, and three months.
2. What Did They Find?
Jaw function improved over time in both the CBD and placebo groups — but there was no statistically significant difference between them
CBD did not significantly reduce pain compared to placebo at any measurement point
Both groups improved across the trial — suggesting a meaningful placebo response or natural improvement over time
CBD was well tolerated with no significant adverse events
The researchers concluded that while jaw function improved with time, CBD could not be identified as the cause
3. What This Means
This is another important null result — and one worth understanding in context. TMJ disorder, like fibromyalgia, is a condition with a notably strong placebo response in clinical trials. When both groups improve, it becomes very difficult to attribute improvement to the treatment rather than to natural fluctuation, time, or expectation.
The absence of an effect doesn't mean CBD has no biological activity in this area — it means this trial, in this population, at this dose, could not detect one above and beyond placebo. That distinction matters.
4. What This Does NOT Mean
This does not mean CBD has no role in oral or facial pain — this was one trial in one specific condition
The improvement in jaw function in both groups is not a negative finding — it may reflect natural course of the condition
The specific CBD product used was funded by the manufacturer, which is a limitation worth noting
Different doses, delivery methods, or cannabinoid combinations may produce different results
Larger trials in other orofacial pain conditions may still find a signal
5. Bottom Line
The first randomized trial of oral CBD for jaw muscle pain found it improved jaw function — but so did the placebo — with no significant pain reduction attributable to CBD, adding to the picture of cannabinoids in conditions with strong placebo responses.
